Originally published by our sister publication, Pain Medicine News
Half of all buprenorphine opioid use disorder (OUD) treatment in the United States was prescribed by only 5% of prescribers in 2017 and 2018, according to a research letter in JAMA (2021;325[21]:2206-2208).
Active prescribers were led by primary care physicians (43.8%), followed by advanced practice providers (20.6%), pain specialists (8.0%) and psychiatrists (14.7%).
“Buprenorphine is one of the most effective treatments for